Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China · Delayed Price · Currency is CNY 13.48
-1.06 (-7.29%)
Aug 20, 2026, 3:04 PM CST
3.96% (1Y)
| Market Cap | 5.63B +4.0% |
| Revenue (ttm) | 459.02M +8.7% |
| Net Income | 33.80M -47.6% |
| EPS | 0.08 -45.3% |
| Shares Out | 417.60M |
| PE Ratio | 168.50 |
| Forward PE | n/a |
| Dividend | 0.06 (0.41%) |
| Ex-Dividend Date | Jun 12, 2026 |
| Volume | 55,806,479 |
| Open | 11.80 |
| Previous Close | 14.54 |
| Day's Range | 11.80 - 15.00 |
| 52-Week Range | 9.01 - 16.95 |
| Beta | 0.51 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 25, 2026 |